Start with what you need treated.

Spinal dysraphism treatment surgically addresses a group of congenital conditions where the spine and spinal cord fail to form or close completely during fetal development, ranging from more severe open defects like myelomeningocele, where spinal cord tissue is exposed, to milder closed defects. For open spinal defects, surgery is typically performed within the first days of life, or in some specialized centers, even before birth, to close the defect and cover the exposed spinal cord and nerves with skin and soft tissue, aiming to prevent infection and further neurological damage. The procedure is performed under general anesthesia by a specialized pediatric neurosurgical team, with careful, delicate technique required given the fragile nature of the exposed neural tissue in more severe cases. Children with spinal dysraphism often require ongoing, coordinated multidisciplinary care throughout childhood, addressing associated issues that can include hydrocephalus, bladder and bowel function, and mobility, extending well beyond the initial surgical repair. Long-term outcomes vary considerably depending on the specific type and severity of the defect, with early surgical treatment aimed at minimizing further neurological damage and providing the best possible foundation for the child's subsequent development and function.

Spinal stenosis treatment typically begins with conservative measures, including physical therapy focused on core strengthening and postural exercises, anti-inflammatory medications, and sometimes epidural steroid injections to reduce inflammation and provide temporary pain relief around the compressed nerves, all aimed at managing symptoms of narrowing within the spinal canal that puts pressure on spinal nerves. For patients whose symptoms, commonly including back pain, leg pain, numbness, or difficulty walking longer distances, do not adequately improve with these conservative measures, or in cases of significant nerve compression causing progressive weakness, surgical decompression, called a laminectomy, to remove the bone and tissue causing the narrowing and relieve pressure on the nerves may be recommended. Surgery is performed under general anesthesia and, for straightforward decompression without the need for fusion, typically takes one to two hours, with many patients experiencing meaningful improvement in walking ability and reduced leg pain within weeks of surgery. Conservative treatment is managed entirely on an outpatient basis over a period of weeks to months to assess response before considering surgical options. Most patients, whether treated conservatively or surgically, experience significant improvement in their symptoms and ability to walk and function comfortably.

Spinal cord detethering surgery addresses tethered cord syndrome, a condition where the spinal cord becomes abnormally attached to surrounding tissue, often at its lower end, preventing it from moving freely within the spinal canal as the child grows, which causes progressive stretching and tension on the spinal cord leading to worsening neurological symptoms over time, including leg weakness, bladder or bowel dysfunction, and back or leg pain. Using an operating microscope for enhanced precision, the surgeon carefully identifies and releases the abnormal attachment, whether from a fatty mass, scar tissue from previous surgery, or other tethering tissue, freeing the spinal cord to move normally and relieving the ongoing tension causing progressive symptoms. The procedure is performed under general anesthesia and typically takes two to four hours, requiring meticulous microsurgical technique to safely work around the delicate spinal cord and nerve roots. Patients are typically advised to remain lying flat for a period after surgery to protect the surgical site and reduce the risk of cerebrospinal fluid leakage. The primary goal of surgery is to halt further progression of neurological symptoms, with some patients also experiencing improvement in pre-existing symptoms, particularly when surgery is performed before long-standing, severe damage has occurred.

TLIF (Transforaminal Lumbar Interbody Fusion) treats conditions of the lower back such as degenerative disc disease, spinal instability, or spondylolisthesis (where one vertebra slips forward relative to another), by removing the damaged disc through a posterior approach angled to the side (transforaminal), which reduces the amount of spinal nerve retraction needed compared to some other fusion techniques, and then placing a bone graft-filled cage into the empty disc space to restore proper disc height and promote fusion. The surgeon also places screws and rods along the back of the spine to add additional stability while the fusion heals and solidifies over the following months. The procedure is performed under general anesthesia and typically takes two to four hours depending on the number of spinal levels being treated. Patients generally begin walking with assistance within a day of surgery, with a structured recovery program guiding a gradual increase in activity over the following weeks to months as the fusion heals. Most patients experience significant relief from back and leg pain related to nerve compression and spinal instability, along with improved spinal stability once the fusion is fully solid.

Vertebroplasty and kyphoplasty are minimally invasive procedures used to treat painful vertebral compression fractures, most commonly caused by osteoporosis, where a weakened vertebra collapses under normal body weight or minor trauma, causing significant back pain. In vertebroplasty, the surgeon guides a needle through the skin directly into the fractured vertebra under X-ray guidance and injects medical-grade bone cement, which hardens quickly to stabilize the fracture and reduce the pain caused by fracture movement. Kyphoplasty adds an additional step, first inflating a small balloon within the fractured vertebra to help restore some of its height and create a cavity before injecting the cement, which can also help correct some of the spinal curvature caused by the fracture. Both procedures are performed under local anesthesia with sedation, or sometimes general anesthesia, typically taking 30 minutes to an hour depending on the number of vertebrae being treated. Most patients experience rapid, often dramatic pain relief within a day or two of the procedure, with minimal recovery time needed and most returning to normal activities quickly. These procedures provide an effective, minimally invasive option for patients with painful compression fractures who have not adequately improved with conservative pain management.

Heart transplant is performed for patients with end-stage heart failure who have exhausted other treatment options, including medications and, in some cases, mechanical heart support devices, offering the best chance of significantly extended survival and greatly improved quality of life. The diseased heart is removed and replaced with a healthy donor heart, matched based on blood type, body size, and other compatibility factors, with the surgery performed under general anesthesia using cardiopulmonary bypass to maintain circulation while the heart is replaced. This is a major, complex operation typically taking four to six hours. Patients require intensive post-operative care initially in an intensive care unit, with lifelong immunosuppressive medication essential to prevent the body's immune system from rejecting the new heart, along with regular heart biopsies in the early period after transplant to monitor for rejection. Close, ongoing monitoring for rejection, infection, and other complications continues indefinitely, with more frequent follow-up visits in the first year after transplant. With modern surgical techniques and immunosuppression protocols, the majority of heart transplant recipients achieve substantially extended survival and a significantly improved quality of life compared to their condition before transplant.

Prostate cancer treatment is highly individualized based on the cancer's grade, stage, and the patient's overall health and life expectancy, ranging from active surveillance, involving close monitoring with regular PSA tests and biopsies for very low-risk, slow-growing cancers that may never require active treatment, to more aggressive treatment including surgery or radiation therapy for higher-risk disease. Surgical treatment, radical prostatectomy, removes the entire prostate gland, increasingly performed using robotic-assisted techniques for improved precision, while radiation therapy, delivered either as external beam radiation over several weeks or as internally placed radioactive seeds (brachytherapy), offers an effective non-surgical alternative with comparable cancer control for many patients. For more advanced disease, hormonal therapy, which reduces testosterone levels that fuel prostate cancer growth, is used alone or in combination with other treatments. Treatment decisions carefully weigh the cancer's aggressiveness against the potential side effects of treatment, particularly regarding urinary and sexual function, with shared decision-making between patient and physician being an important part of the process. Regular PSA monitoring after treatment tracks for any signs of cancer recurrence, with the majority of patients diagnosed with localized prostate cancer achieving excellent long-term survival regardless of the specific treatment approach chosen.

Kidney stone treatment depends significantly on the stone's size, location, and composition, with many small stones passing on their own with conservative management including increased fluid intake and pain medication, while larger or more problematic stones causing significant pain, blockage, or infection require active intervention. Shock wave lithotripsy uses focused sound waves delivered from outside the body to break larger stones into smaller fragments that can then pass more easily, performed as an outpatient procedure under light sedation. For stones that are too large, too hard, or in a location not well suited to lithotripsy, ureteroscopy, where a thin scope is passed through the urinary tract to directly visualize and break up or remove the stone, or in some cases, percutaneous nephrolithotomy for very large stones, may be necessary, both performed under anesthesia. Following treatment, patients are often advised on dietary and fluid intake modifications, and sometimes medication, to reduce the risk of forming new stones in the future, particularly if stone analysis reveals a specific composition amenable to targeted prevention strategies. Most patients experience effective stone clearance and significant symptom relief with appropriately selected treatment based on their specific stone characteristics.

Bladder cancer treatment depends significantly on how deeply the cancer has invaded the bladder wall, with early-stage, non-muscle-invasive cancer typically treated with transurethral resection of the bladder tumor (TURBT), a minimally invasive procedure performed through the urethra to remove the tumor without any external incision, often followed by instillation of medication directly into the bladder to reduce the risk of recurrence. For more advanced, muscle-invasive bladder cancer, more extensive treatment is generally needed, which may include radical cystectomy, complete surgical removal of the bladder along with creation of a new way for urine to exit the body, combined with chemotherapy given before or after surgery to improve long-term outcomes. TURBT is a relatively quick outpatient or short-stay procedure performed under general or spinal anesthesia, while radical cystectomy is major surgery requiring a longer hospital stay and more extensive recovery. Because bladder cancer has a tendency to recur even after successful initial treatment, regular follow-up cystoscopy examinations are an essential, ongoing part of care for years after treatment. Most patients with early-stage bladder cancer achieve good long-term outcomes with appropriate treatment and consistent surveillance.

Bladder prolapse, or cystocele, occurs when weakened pelvic floor muscles and connective tissue, often related to childbirth, menopause, or chronic straining, allow the bladder to sag and bulge into the front wall of the vagina, causing symptoms such as pelvic pressure, urinary difficulties, or a noticeable vaginal bulge. Milder cases are often managed with pelvic floor physical therapy to strengthen supporting muscles, or with a pessary, a supportive device inserted into the vagina to help hold the bladder in a more normal position, both effective non-surgical options for appropriate candidates. For more significant prolapse causing bothersome symptoms not adequately relieved by conservative measures, surgical repair, performed entirely through the vagina under general or spinal anesthesia, tightens and reinforces the weakened tissue to restore proper bladder support. Surgery typically takes one to two hours, with patients advised to avoid heavy lifting and straining for about six weeks during the healing period. Most patients experience significant improvement in prolapse symptoms and associated urinary function following appropriate treatment, whether conservative or surgical, tailored to their specific situation and severity.

Hematuria evaluation focuses on identifying the underlying cause of blood appearing in the urine, which can range from relatively benign and easily treatable causes such as urinary tract infection or kidney stones, to less common but more serious causes including tumors of the kidney or bladder, making thorough investigation important even when symptoms are otherwise mild. The diagnostic workup typically includes detailed urine testing to look for infection or abnormal cells, blood tests to assess kidney function, and imaging studies such as a CT scan or ultrasound to visualize the kidneys and urinary tract for stones, tumors, or other abnormalities. Cystoscopy, using a thin scope to directly examine the inside of the bladder, is often performed, particularly in older patients or those with risk factors for bladder cancer, to directly visualize the bladder lining for any concerning areas. This diagnostic process is typically conducted entirely on an outpatient basis over one or more visits, with the specific tests tailored based on initial findings and the patient's risk factors. Once the underlying cause is identified, treatment is directed at that specific condition, whether it be antibiotics for infection, stone treatment, or further evaluation and treatment if a tumor is identified. Most causes of hematuria, once properly identified, are effectively treated.

Erectile dysfunction treatment begins with identifying contributing factors, which can include cardiovascular disease, diabetes, hormonal imbalances, psychological factors, certain medications, or lifestyle factors such as smoking, since addressing underlying medical conditions is often an important part of comprehensive treatment. Oral medications, phosphodiesterase-5 inhibitors, are typically the first-line treatment for most men, working to enhance blood flow to the penis to facilitate erections in response to sexual stimulation, and are effective for the majority of men when appropriately prescribed. For men who do not respond adequately to oral medication, or who cannot take these medications due to other health conditions, additional options include injectable medications, vacuum erection devices, or in some cases, a surgically implanted penile prosthesis for more definitive, long-term treatment. Lifestyle modifications, including regular exercise, smoking cessation, and management of underlying conditions like diabetes or high blood pressure, can also meaningfully improve erectile function for many men. Treatment is managed entirely on an outpatient basis, with the specific approach tailored to the individual's underlying causes, preferences, and response to initial treatment options. Most men achieve significant improvement in erectile function with appropriately selected treatment.